Scarica l'app Stockscreener
3.10
5.03%
0.12
Precedente Chiudi:
$2.98
Aprire:
$3
Volume 24 ore:
2,274
Relative Volume:
0.01
Capitalizzazione di mercato:
$25.04M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.88%
1M Prestazione:
-26.53%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$3.00
$3.1949
Intervallo di 1 settimana:
$2.92
$3.36
Portata 52W:
$2.74
$8.50
Firefly Neuroscience Inc Stock (AIFF) Company Profile
Nome
Firefly Neuroscience Inc
Settore
Industria
Telefono
888-237-6412
Indirizzo
1100 MILITARY ROAD, KENMORE
Confronta AIFF con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| AIFF | 3.1006 | 25.04M | 0 | 0 | 0 | 0.00 |
| CRM | 331.62 | 309.29B | 36.47B | 5.63B | 11.46B | 1.59 |
| SAP | 234.24 | 271.00B | 36.09B | 2.98B | 7.67B | 5.2918 |
| NOW | 1,033.67 | 209.86B | 10.46B | 1.34B | 3.35B | 7.72 |
| INTU | 667.29 | 180.93B | 16.29B | 2.96B | 4.63B | 8.44 |
| UBER | 70.16 | 146.00B | 41.96B | 4.40B | 5.96B | -0.22 |
Firefly Neuroscience Inc Borsa (AIFF) Ultime notizie
Bright Minds Biosciences participates in a conference call with Truist - Nasdaq
Firefly Neuroscience Third Quarter 2024 Earnings: US$0.61 loss per share (vs US$0.18 loss in 3Q 2023) - Yahoo Finance
Information Analysis Incorporated : Announces $2,800,000 Equity Financing - Marketscreener.com
Firefly Neuroscience Inc (AIFF) Quarterly 10-Q Report - Quartzy
Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update - The Manila Times
Reklaim Ltd (MYID-X) QuotePress Release - The Globe and Mail
Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update - GlobeNewswire Inc.
4 Biotech Stocks With AI, Machine Learning Prowess - Investing.com
Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event - The Manila Times
Nano Nuclear Energy Inc (NNE-Q) QuotePress Release - The Globe and Mail
Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Arbor Realty Trust Schedules Third Quarter 2024 Earnings Conference Call - ForexTV.com
Midnight Sun Mining Corp (MDNGF) QuotePress Release - The Globe and Mail
Gold prices fall but record highs remain in sight - Investing.com
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Bright Minds and Firefly Neuroscience Renew Collaboration - TipRanks
What's Going On With Bright Minds Biosciences Stock? - Benzinga
Bright Minds, Firefly Neuroscience Shares Rise on Collaboration for Clinical Trial Analysis - MarketWatch
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Bright Minds, Firefly Neuroscience to collaborate after BREAKTHROUGH study - TipRanks
Atossa Therapeutics to Participate in Fireside Chat with Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer - The Manila Times
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data - ForexTV.com
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Manhattan Associates (MANH) Stock Dips 1.52% Amid Broader Softwa - GuruFocus.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis - Benzinga
Firefly and Bright Minds collaborate on brain health AI - Investing.com India
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views - Benzinga
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results - MSN
Firefly and Bright Minds collaborate on brain health AI By Investing.com - Investing.com South Africa
Firefly Neuroscience, Bright Minds collaborate to analyze study data on BMB-101 - TipRanks
Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology - The Manila Times
Biotech Alert: Searches spiking for these stocks today - TipRanks
Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder - The Manila Times
Firefly Neuroscience to Participate in Upcoming October Investor Conferences - EIN News
Arrivo BioVentures Begins Phase 1 Study of SP-624, the First Potential Treatment Specifically for Women with Major Depressive Disorder - Business Wire
Firefly Neuroscience, Zeto Agree To EEG Headset Distribution Deal - MPO-mag
Firefly Neuroscience, Zeto Agree to EEG Headset Distribution Deal - MPO-mag
AIFF stock touches 52-week low at $2.74 amid market challenges - Investing.com Australia
AIFF stock touches 52-week low at $2.74 amid market challenges By Investing.com - Investing.com South Africa
Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events - StockTitan
AIFF Stock Hits 52-Week Low at $2.99 Amid Market Challenges - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.62% - Investing.com
Firefly Neuroscience Inc Azioni (AIFF) Dati Finanziari
Non sono disponibili dati finanziari per Firefly Neuroscience Inc (AIFF). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
23.22%
1.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):